- A statement released on the website of China’s Ministry of Public Security referencing the record $3 billion fine that British pharmaceutical company GlaxoSmithKline received last year from the United States. GSK is under investigation for corrupt practices in its mainland China operations. (9/4/2013)
SOURCE: South China Morning Post
POSTED BY: Ethan Robertson on Thursday, Sept. 19, 2013
SOURCE: South China Morning Post
POSTED BY: Ethan Robertson on Thursday, Sept. 19, 2013